Trevi Therapeutics Inc

TRVINASDAQ · USD
14.89USD0.00 (-0.41%)
229

Trevi Therapeutics Inc (TRVI) Option Chain

As of September 21, 2026, Trevi Therapeutics Inc is trading at $14.89, a -0.41% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 45.2%. IV Rank is 3%.

Read more

Tracking the TRVI option chain helps you see every strike and expiry on Trevi Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Trevi Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of TRVI options activity at a glance. Use our scanner to monitor the TRVI option chain in real time and filter for the TRVI options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For TRVI stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the TRVI option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where TRVI stock options are being actively traded and where they are not.

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Trevi Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen TRVI options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of TRVI stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile26.59% Subdued
  • Market cap (M$)2,121
  • 52 weeks high-26.36%
  • 52 weeks low85.20%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$29.50
    98.12% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-12
  • P/E
  • Future P/E
  • EPS (ttm)-0.34
  • EPS growth next 5 years

As of September 21, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
13.158800.181.891.902.2513.00-12.690.050.250.000.15013286.85
31.255600.360.891.101.4014.00-5.981.100.001.100968.75
53.925015800.680.000.550.8015.00+0.740.600.850.110.62756946.08
74.14455220.250.000.200.3016.00+7.451.251.501.110.2713325.86
87.772,52210.300.000.050.5517.00+14.172.052.402.110.12117412.23

As of September 21, 2026

Scan the full option chain in one place

Browse the full TRVI option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial